DK1812009T3 - GABA-steroidantagonister og deres anvendelse til behandling af CNS-lidelser - Google Patents
GABA-steroidantagonister og deres anvendelse til behandling af CNS-lidelserInfo
- Publication number
- DK1812009T3 DK1812009T3 DK05801885.4T DK05801885T DK1812009T3 DK 1812009 T3 DK1812009 T3 DK 1812009T3 DK 05801885 T DK05801885 T DK 05801885T DK 1812009 T3 DK1812009 T3 DK 1812009T3
- Authority
- DK
- Denmark
- Prior art keywords
- gaba
- treatment
- cns disorders
- steroid antagonists
- steroid
- Prior art date
Links
- -1 GABA steroid Chemical class 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 208000015114 central nervous system disease Diseases 0.000 title 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Anesthesiology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62951104P | 2004-11-18 | 2004-11-18 | |
| PCT/SE2005/001671 WO2006054938A1 (en) | 2004-11-18 | 2005-11-07 | Gaba-steroid antagonists and their use for the treatment of cns disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1812009T3 true DK1812009T3 (da) | 2013-08-05 |
Family
ID=36407411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05801885.4T DK1812009T3 (da) | 2004-11-18 | 2005-11-07 | GABA-steroidantagonister og deres anvendelse til behandling af CNS-lidelser |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8114860B2 (https=) |
| EP (1) | EP1812009B1 (https=) |
| JP (1) | JP4914368B2 (https=) |
| CN (1) | CN101076340B (https=) |
| AU (1) | AU2005307151B2 (https=) |
| BR (1) | BRPI0518359A2 (https=) |
| CA (1) | CA2585359C (https=) |
| DK (1) | DK1812009T3 (https=) |
| ES (1) | ES2423493T3 (https=) |
| MX (1) | MX2007006032A (https=) |
| WO (1) | WO2006054938A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006054938A1 (en) | 2004-11-18 | 2006-05-26 | Umecrine Ab | Gaba-steroid antagonists and their use for the treatment of cns disorders |
| DK2097437T3 (en) * | 2006-11-21 | 2015-06-29 | Umecrine Cognition Ab | THE USE OF PREGNANCY AND ANDROSTANOSTEROIDS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CNS DISEASES |
| CN101585862B (zh) * | 2008-05-20 | 2014-12-17 | 梅克芳股份公司 | 甾族化合物 |
| US20110086828A1 (en) * | 2009-10-07 | 2011-04-14 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Treatment of alcohol abuse and alcoholism using modulators of neurosteroid binding sites on gabaa receptors |
| HUE027298T2 (en) | 2010-01-14 | 2016-10-28 | Asarina Pharma Ab | Pharmaceutical composition containing developed storage and dissolution properties containing 3-beta-hydroxy-5-alpha-pregnan-20-one |
| WO2023148234A1 (en) | 2022-02-04 | 2023-08-10 | Rousselot Bv | Use of collagen hydrolysate in prevention and/or treatment of food craving |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4614499A (en) * | 1985-04-29 | 1986-09-30 | Universite Laval | Simulator for use as a neurosurgical aid in determining potential paths for the implantation of probes through the human body |
| CN1270718C (zh) * | 1998-03-11 | 2006-08-23 | 托布乔恩·贝克斯托罗姆 | 表别孕烷醇酮在制备治疗甾族化合物诱导的疾病的药物中的应用 |
| US20030125311A1 (en) * | 2000-03-17 | 2003-07-03 | Etienne-Emile Baulieu | Compounds capable of binding with the cytoskeleton |
| FR2806303B1 (fr) * | 2000-03-17 | 2002-09-27 | Inst Nat Sante Rech Med | Composes capables de se lier a des proteines constituantes ou associees aux elements du cytosquelette et leurs applications pour la fabrication de medicaments |
| SE0104423D0 (sv) * | 2001-12-27 | 2001-12-27 | Umecrine Ab | Pregnane steroids and their use in the treatment of CNS disorders |
| WO2006054938A1 (en) | 2004-11-18 | 2006-05-26 | Umecrine Ab | Gaba-steroid antagonists and their use for the treatment of cns disorders |
-
2005
- 2005-11-07 WO PCT/SE2005/001671 patent/WO2006054938A1/en not_active Ceased
- 2005-11-07 MX MX2007006032A patent/MX2007006032A/es active IP Right Grant
- 2005-11-07 ES ES05801885T patent/ES2423493T3/es not_active Expired - Lifetime
- 2005-11-07 US US11/791,160 patent/US8114860B2/en not_active Expired - Fee Related
- 2005-11-07 EP EP05801885.4A patent/EP1812009B1/en not_active Expired - Lifetime
- 2005-11-07 AU AU2005307151A patent/AU2005307151B2/en not_active Ceased
- 2005-11-07 BR BRPI0518359-6A patent/BRPI0518359A2/pt not_active IP Right Cessation
- 2005-11-07 DK DK05801885.4T patent/DK1812009T3/da active
- 2005-11-07 CN CN2005800394888A patent/CN101076340B/zh not_active Expired - Fee Related
- 2005-11-07 JP JP2007542970A patent/JP4914368B2/ja not_active Expired - Fee Related
- 2005-11-07 CA CA2585359A patent/CA2585359C/en not_active Expired - Fee Related
-
2012
- 2012-02-13 US US13/372,389 patent/US8372824B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1812009A4 (en) | 2010-08-11 |
| JP4914368B2 (ja) | 2012-04-11 |
| AU2005307151A1 (en) | 2006-05-26 |
| BRPI0518359A2 (pt) | 2008-11-18 |
| MX2007006032A (es) | 2007-10-17 |
| US8114860B2 (en) | 2012-02-14 |
| JP2008525317A (ja) | 2008-07-17 |
| CN101076340A (zh) | 2007-11-21 |
| US20080070876A1 (en) | 2008-03-20 |
| US8372824B2 (en) | 2013-02-12 |
| CA2585359A1 (en) | 2006-05-26 |
| EP1812009A1 (en) | 2007-08-01 |
| WO2006054938A1 (en) | 2006-05-26 |
| CA2585359C (en) | 2013-01-08 |
| AU2005307151B2 (en) | 2011-10-20 |
| EP1812009B1 (en) | 2013-05-15 |
| ES2423493T3 (es) | 2013-09-20 |
| CN101076340B (zh) | 2011-01-12 |
| US20120142657A1 (en) | 2012-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1765322T3 (da) | Retinal-derivater og fremgangsmåder til anvendelse deraf i behandlingen af synsforstyrrelser | |
| DK1928886T3 (da) | Pyridin-derivater og deres anvendelse i behandlingen af psykotiske lidelser | |
| DK1663978T3 (da) | Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser | |
| DK1917246T3 (da) | Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme | |
| DK1919450T3 (da) | Antihistamin- og corticosteroidholdig liposomsammensætning og dens anvendelse til fremstilling af et lægemiddel til behandling af rhinitis og beslægtede lidelser | |
| DK1727567T3 (da) | Aptamer-terapeutiske midler nyttige i behandling af komplementrelaterede forstyrrelser | |
| DK2084151T3 (da) | Substituerede dihydropyrazoloner til behandling af kardiovaskulære og hæmatologiske sygdomme | |
| DK1830838T3 (da) | Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme | |
| DK1755743T3 (da) | Beta-hydroxybutyrat og derivater til behandling af depression og angst | |
| DK1828202T3 (da) | Rapamycinanaloge samt deres anvendelse ved behandling af neurologiske, proliferative og inflammatoriske lidelser | |
| DK1615909T3 (da) | Piperazin-derivater og deres anvendelse til behandling af neurologiske og psykiatriske sygdomme | |
| DK1824475T3 (da) | Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol | |
| DK1805312T3 (da) | Fremgangsmåder og midler til fremstilling af hyaluronan | |
| DK1988777T3 (da) | Pyrazoler til behandling af fedme og andre cns-lidelser | |
| ZA200607433B (en) | Methods and compositions for the treatment of gastroin-testinal disorders | |
| DK1660057T3 (da) | Kombinationsterapi til behandling af neovaskulære øjenlidelser | |
| DK1713503T3 (da) | Hæmning af faktor b, den alternative komplemenpathway og dertil relaterede fremgangsmåde | |
| DK1951866T3 (da) | Delta-9-elongaser og anvendelse heraf til fremstilling af flerumættede fedtsyrer | |
| DK2526858T3 (da) | Vurdering af søvnkvalitet og søvnvejrtrækningsforstyrrelser baseret på hjerte-lunge-kobling | |
| DK2796469T3 (da) | Hidtil ukendte sammensætninger og fremgangsmåder til behandling af IgE-medierede forstyrrelser | |
| DK1644021T3 (da) | Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme | |
| DK2952178T3 (da) | Oftalmiske sammensætninger og fremgangsmåder til behandling af øjne | |
| DK2124997T3 (da) | Anvendelse af IL-1-antagonister til behandling af gigt og pseudogigt | |
| DK1530466T3 (da) | Anvendelse af nintedanib til behandling af lungefibrose | |
| DK1651234T3 (da) | Kombination af en mglur2-antagonist og ache-inhibitor til behandling af akutte og/eller kroniske neurologiske lidelser |